BioSpace News Archive

The webcast will be recorded, and will be available for replay via the website until 5:00 p.m. Mountain Time on Friday, December 13, 2019.

Company secures first purchase commitment for 2020 and expands GoodWheat harvest acres ten-fold over prior year

Verona Pharma plc, a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for respiratory diseases, announces an operational update and financial results for the three months and nine months ended September 30, 2019.

Amarin Corporation plc, a pharmaceutical company focused on improving cardiovascular health, announced financial results for the three and nine months ended September 30, 2019 and provided an update on company operations.

Advanced Elastomer Formulation and AccelTRA® Line Extension Components Expand Company’s Drug Containment and Delivery Portfolio; West Marks First Anniversary of Integrated Solutions Program

IDEAYA Biosciences, Inc. announced that Dr. Paul A. Barsanti, Ph.D., has joined IDEAYA as Vice President, Head of Drug Discovery, to help advance the company’s ongoing preclinical research programs.

Avantor, Inc., a leading global provider of mission critical products and services to customers in the life sciences and advanced technologies & applied materials industries, reported financial results for the quarter ended September 30, 2019.

Plenity-treated adults achieving a BMI of <27 lost an average of 13.5% of their weight with the rate of weight loss tapering as participants approached a healthy BMI goal

H.I.G. BioHealth Partners, the dedicated healthcare investment affiliate of H.I.G. Capital, a leading global private equity investment firm with over $34 billion of equity capital under management,* co-led an $18M commercialization round for Clarify Medical, a medical device company committed to developing products and services to treat chronic skin conditions.

Believes Claims are Without Merit and an Attempt to Suppress Innovation and Competition